Growth Hormone Secretagogues (GHS) Peptides
Source authentic growth hormone secretagogues (GHS) and releasing hormone (GHRH) analogs. Designed for studying pituitary somatotroph signaling, IGF-1 regulation, and lean tissue synthesis. Featuring CJC-1295 DAC & No DAC, Ipamorelin, Tesamorelin, Sermorelin, MK-677, and IGF-1 LR3.
Key Specifications & Live Sourcing Metrics: Growth Hormone Secretagogues (GHS) Peptides
Primary laboratory research specifications, pricing benchmarks, purity verifications, and domestic fulfillment data for Growth Hormone Secretagogues (GHS) Peptides.
Verified In-Stock Compounds
Showing active catalog batchesFrequently Asked Questions
What is the functional difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC contains a Drug Affinity Complex that covalently binds to circulating serum albumin, extending its biological half-life to approximately 6–8 days. CJC-1295 without DAC (Mod GRF 1-29) lacks the bioconjugation moiety and has a half-life of ~30 minutes, producing natural pulsatile growth hormone release.
Why are CJC-1295 and Ipamorelin frequently combined in research?
CJC-1295 acts on GHRH receptors, while Ipamorelin is a selective ghrelin/GHS-R1a receptor agonist. When co-administered, they synergistically amplify pituitary growth hormone release without elevating cortisol, prolactin, or aldosterone levels.
What makes Tesamorelin distinct from other GHRH analogs?
Tesamorelin is a 44-amino acid peptide stabilized with a hexenoyl group at its N-terminus. It exhibits superior resistance to dipeptidyl peptidase-4 (DPP-4) enzymatic degradation compared to native GHRH.
Need Custom Synthesis or Bulk Research Compounds?
Contact our laboratory support team for volume pricing, custom mg formulation, and batch-specific analytical documentation.